GAITHERSBURG, MD – June 13, 2017 – The Institute for In Vitro Sciences (IIVS), a leader in non-animal test methods, marked its 20th year with the opening of a new state-of-the-art in vitro respiratory exposure laboratory. The 1,000 square foot facility expands IIVS’ non-animal testing...
Read the latest issue of our e-newsletter for an update on our new respiratory toxicology laboratory and an article by IIVS Study Director, Dr. G. Emilia Costin, on testing strategies for evaluating the potential of ingredients and products to modulate skin color. View issue....
ECHA’s third report on the use of alternative methods under REACH shows that most registrants consider and use alternatives to animal testing. One effective way is data sharing: 98 % of the substances are registered jointly. Registrants also make extensive use of existing information and...
When entrepreneur Phoebe Song launched her organic, vegan skincare line, she had big plans to sell around the world, including in China, the world's largest consumer market. But she stopped cold after learning that the Chinese government mandated animal testing for imported cosmetics and skincare...
IIVS President, Erin Hill, and scientist, Quanshun Zhang attended the Congress on Alternative Methods in Guangzhou China. Dr. Zhang presented on the newly adopted 3T3 Phototoxicity Assay. ...
GAITHERSBURG, MD – January 27, 2017 – The Institute for In Vitro Sciences (IIVS) is proud to announce its 20th anniversary as an international leader in the in vitro (non-animal) testing field. Founded in 1997, IIVS is unique in its position as a high quality...
Skin toxicity testing was the focus of a full-day seminar held during In-Cosmetics 2017. Attendees learned about everything from skin absorption and metabolism, to cytotoxicity, phototoxicity and sensitization. IIVS Study Director, Dr. Tinashe Ruwona, presented on integrated testing strategies to evaluate the skin sensitization potential...
IIVS President, Erin Hill, and Study Director, Tinashe Ruwona are attending the In-Cosmetics Global meeting, April 4-6, in London. Dr. Ruwona, who leads our skin sensitization screening program, presented during the Skin Toxicology Workshop. His presentation, "Integrated Testing Strategies for Assessing the Skin Sensitization Potential of Cosmetics",...
Three regulatory accepted in vitro assays were evaluated in a proof-of-concept project to determine skin sensitization potential of electronic cigarette liquids (eliquids). These assays measure molecular initiating events and initial cellular responses prescribed in the OECD Integrated Testing Strategy (ITS) describing key events in the...
On 8-10 December 2014, IIVS organised a workshop conference, entitled Assessment of In Vitro COPD Models for Tobacco Regulatory Science, to bring together stakeholders representing regulatory agencies, academia, industry and animal protection, to address the research priorities articulated by the FDA-CTP. Specific topics were covered...